Australia Reprocessed Medical Devices Market Is Growing with Increasing Prevalence of Chronic Diseases
To avoid risk of infection by a contaminated device, reusable devices undergo reprocessing, a detailed, multistep process to clean and then disinfect or sterilize them. Reprocessing ensures that reusable medical devices are safe for intended use. Reprocessed medical devices undergo reprocessing procedures and are used again. Reprocessing of a reusable device or single used device undergo steps like disinfection, cleaning, remanufacturing, testing, packaging, labeling, and sterilization, among others. Growth of the Australia reprocessed medical devices market is attributed to the increasing utilization of reprocessed medical devices in the healthcare sector, which in turn, is expected to increasing the demand for such reprocessed devices.
The use of reprocessed devices leads to significant savings
in the healthcare sector. According to Association of Medical Device
Reprocessors, in 2018, reprocessed devices saved surgery centers and hospitals
around US$ 500 million. Cost of reprocessed medical device can be nearly half
the cost of new device and thus can result in huge cost savings. The healthcare
industry can save billions of dollars per year through reprocessing. Moreover, the
Australia reprocessed medical devices market growth mainly is driven by the introduction
of quality management system (QMS) for medical devices.
For instance, in April 2020, Cleanpart launched a quality
management system according to ISO 13485:2016. ISO 13485:2016 specifies
requirements for QMS where an organization needs to demonstrate its ability to
provide medical devices and related services that consistently meet customer
and applicable regulatory requirements. However, the lack of stringent
regulations for such devices can lead to an increase in cases of infection and contamination
due to the use of reprocessed medical devices. Therefore, the risk of hospital
acquired infection and cross contamination is major factor restraining growth
of the Australia reprocessed medical devices market growth.
According to the Centers for Disease Control (CDC), hospital
acquired infections account for an estimated 1.7 million infections and 99,000
associated deaths each year in the United States alone. Moreover, with the
increasing prevalence of chronic disease worldwide, the demand for reprocessed
medical devices is also increasing, driving the Australia reprocessed medical
devices market growth. Thus, market players are adopting various inorganic
strategies to meet the increasing demand for reprocessed medical devices. For
instance, in 2019, ReNu Medical and NEScientific joined the Association of
Medical Device Reprocessors (AMDR).
By participating in AMDR, member companies demonstrate a
collaborative commitment to quality standards, promote education, and expand
reprocessing services to bring increased value to hospitals without sacrificing
care quality.
Comments
Post a Comment